The
Geneva-based WHO is leading a global initiative to develop safe
and effective drugs, tests and vaccines to prevent, diagnose and
treat COVID-19. The respiratory illness caused by the novel
coronavirus has infected 4.19 million people around the world,
according to a Reuters tally.
"We do have some treatments that seem to be in very early
studies limiting the severity or the length of the illness but
we do not have anything that can kill or stop the virus,"
spokeswoman Margaret Harris told a briefing, referring to the
body's so-called Solidarity Trial of drugs against the disease.
"We do have potentially positive data coming out but we need to
see more data to be 100% confident that we can say this
treatment over that one," she added.
The WHO official sounded a note of caution around expectations
for a vaccine, however, saying coronaviruses in general are
"very tricky viruses" that are "difficult to produce vaccines
against". More than 100 potential COVID-19 vaccines are being
developed, including several in clinical trials.
The WHO said in April a vaccine would take at least 12 months.
(Reporting by Emma Farge; Editing by Alison Williams and
Catherine Evans)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|